These anagrelide capsules are being recalled.
Teva issued a recall for Anagrelide Capsules due to dissolution test failure.
Salmonella: Cargill recalls 795 boxes of product
Anagrelide Capsules recall
According to an article by the FDA the company Teva is having a recall on Anagrelide Capsules.
These capsules failed the dissolution test which means they do not dissolve correctly.
If a pill does not dissolve correctly then it becomes less effective.
Only one lot of capsules are affected by this alert.
The product name and lot number are listed below
- Anagrelide Capsules – GD01090
These were distributed nationwide.
Teva notified their customers on May 11, 2022, to inform them of this recall.
Anyone who has these capsules should return them to the company.
FingerLakes1.com is the region’s leading all-digital news publication. The company was founded in 1998 and has been keeping residents informed for more than two decades. Have a lead? Send it to news@fingerlakes1.com.
